Surgical margin Monoclonal antibody Maintenance chemotherapy Antibody Drug Conjugate (ADCs) TNM staging system Complementary therapy Adenocarcinoma CTACAE Clinical stage Cellular therapy Partial Remission Tyrosine kinase inhibitors (TKIs) Adjuvant treatment Chemotherapy Palliation Pathological stage Grade 3, 4, or 5 Minimal residual disease (MRD) Active surveillance Neoadjuvant treatment Relapse Checkpoint inhibitor Tumor leukemia Recurrence ECOG performance status Carcinoma Maintenance chemotherapy performance status Definitive treatment Refractory Cure Complete remission Sarcoma Surgical margin Monoclonal antibody Maintenance chemotherapy Antibody Drug Conjugate (ADCs) TNM staging system Complementary therapy Adenocarcinoma CTACAE Clinical stage Cellular therapy Partial Remission Tyrosine kinase inhibitors (TKIs) Adjuvant treatment Chemotherapy Palliation Pathological stage Grade 3, 4, or 5 Minimal residual disease (MRD) Active surveillance Neoadjuvant treatment Relapse Checkpoint inhibitor Tumor leukemia Recurrence ECOG performance status Carcinoma Maintenance chemotherapy performance status Definitive treatment Refractory Cure Complete remission Sarcoma
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Surgical margin
Monoclonal antibody
Maintenance chemotherapy
Antibody Drug Conjugate (ADCs)
TNM staging system
Complementary therapy
Adenocarcinoma
CTACAE
Clinical stage
Cellular therapy
Partial Remission
Tyrosine kinase inhibitors (TKIs)
Adjuvant treatment
Chemotherapy
Palliation
Pathological stage
Grade 3, 4, or 5
Minimal residual disease (MRD)
Active surveillance
Neoadjuvant treatment
Relapse
Checkpoint inhibitor
Tumor
leukemia
Recurrence
ECOG performance status
Carcinoma
Maintenance chemotherapy
performance status
Definitive treatment
Refractory
Cure
Complete remission
Sarcoma